Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 39 - General protective or antinoxious agents
Patents for A61P 39 - General protective or antinoxious agents (19,019)
12/2005
12/29/2005US20050288285 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
12/29/2005DE102005027905A1 Combating stress states or nervous system or metabolic disorders, using glycine as neurotransmission modulator showing antistress, stress protective, nootropic and toxin binding actions
12/29/2005DE102005026380A1 Mittel zur Unterdrückung von Entzündungen, umfassend Zinkpyrrolidoncarboxylat Means for suppressing inflammation, comprising zinc pyrrolidonecarboxylate
12/28/2005EP1609863A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/28/2005EP1609473A1 Use of acetyl-d-aminoglycosamine in treatment of local lesions and systematic symptoms related to infections of virus or bacteria
12/28/2005EP1435983B1 Concentrate comprising green tea, grape skin extract and grape seed extract, the production thereof and the use of the same
12/28/2005CN1713916A NADH/NADPH-containing compound
12/28/2005CN1713888A Cream for treatment of skin injured by the sun
12/28/2005CN1233351C Production process for extracting liposoluble and water soluble antioxidant from rosemary
12/27/2005US6979747 Antioxidants, preparation processes and their uses
12/22/2005WO2005097814A3 Composition and method for inhibiting platelet aggregation
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005DE102004045186A1 Hydratisierte lamellare Phasen oder Liposomen, enthaltend ein Fettmonoamin oder ein kationisches Polymer, das die intrazelluläre Penetration begünstigt, und kosmetische oder pharmazeutische Zusammensetzungen, diese enthaltend, sowie Screeningverfahren nach einer solchen Substanz Hydrated lamellar phases or liposomes, containing a fatty mono-amine or a cationic polymer that promotes intracellular penetration, and cosmetic or pharmaceutical compositions comprising them, as well as screening methods for such substance
12/22/2005DE102004025601A1 Vitaminization of materials, e.g. bed, comprises impregnation of vitamins during the fabrication of the materials, where the vitamins are repeatedly added during the use and added along with prefabricated solutions and powders
12/21/2005EP1606021A1 Manganese based organometallic complexes, pharmaceutical compositions and dietetic products
12/21/2005EP1605947A1 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005EP1223915B1 Dry powder compositions having improved dispersivity
12/21/2005CN1711099A Extract with anti-tumor and anti-poisonous activity
12/21/2005CN1232252C Retard release preparation containing alpha-lipoic acid (derivatives)
12/21/2005CN1232188C Method for processing ginseng and processed ginseng obtained by the same
12/20/2005US6977267 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/15/2005WO2005079506A3 Systemic immune activation method using nucleic acid-lipid complexes
12/15/2005US20050276893 Method for producing fat and/or solids from beans and compositions containing polyphenols
12/15/2005US20050274391 Means for weaning people off smoking and alcohol
12/14/2005EP1603532A1 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders
12/14/2005EP1603409A2 Salutary compositions consisting of fungi containing lipids and thiocyanates
12/14/2005EP1242104B1 Process of obtaining thylakoids from plants, pure thylakoids and use thereof
12/14/2005CN1706378A Composition for treating inflammation which contains zinc pyrrolidonecarboxylate
12/14/2005CN1231495C Imidazoline substituted phenoxyacetyl oligopeptide compounds, their synthesis and medical uses
12/14/2005CN1231494C Imidazoline substituted phenoxyacetyl oligopeptide compounds, their synthesis and application in medicine
12/14/2005CA2509007A1 Agents for producing the health-benefits of repeated exercise
12/13/2005US6974840 Therapeutic agents
12/08/2005WO2005116005A1 Epigallocatechin dimer and trimer having lipase inhibitory activity and/or antioxidative activity
12/08/2005WO2005082860A8 Tetracyclines and their use as calpain inhibitors
12/08/2005US20050271728 High molecular weight medicine-containing preparation in powder form for administration through mucosa
12/08/2005US20050271632 Methods of modulating hair growth
12/08/2005US20050271606 Composition for treating inflammation which contains zinc pyrrolidonecarboxylate
12/08/2005US20050271603 Compositions comprising lactoferrin
12/08/2005CA2566373A1 2-substituted 17-imino estrogen compounds for cytoprotection
12/08/2005CA2564592A1 Compositions for improving breast health in women
12/07/2005EP1602704A1 Antioxidant, skin preparation for external use, cosmetic and food
12/07/2005EP1303269B1 Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators
12/07/2005EP1296639B1 Use of green-light emitting materials in pharmaceutical compositions
12/07/2005EP1196129B1 Pharmaceutical and cosmetic compositions comprising urocanic acid derivatives as radical scavengers or antioxidants
12/07/2005EP1155019B1 Substituted porphyrins and their therapeutic use
12/07/2005CN1705471A Deferacirox dispersible tablets
12/07/2005CN1230416C Pharmaceutical compounds
12/01/2005US20050267137 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof
12/01/2005US20050267042 Method and preparation for binding acetaldehyde in saliva, stomach and large intestine
12/01/2005US20050267038 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
12/01/2005US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders
12/01/2005US20050266532 Albumin fusion proteins
12/01/2005US20050266065 Hydrated lamellar phases or liposomes which contain a fatty monoamine or a cationic polymer which promotes intracellular penetration, and a cosmetic or pharmaceutical composition containing same, as well as a method of screening such a substance
11/2005
11/30/2005EP1317483B1 Variants of allergenic proteins of the group 2 of dermatophagoides
11/30/2005EP1079832B1 Use of vitamin pp compounds
11/30/2005EP1071474B1 Substituted porphyrins
11/30/2005CN1701792A Preparation for external use on skin
11/30/2005CN1229371C Benzopyranyl guanidine derivtives, process for preparation thereof and pharmaceutical compositions containing them
11/29/2005US6969707 For therapy or inhibiting the development of a pathology associated with peroxynitrite damage
11/28/2005CA2508093A1 Preparation for external use on skin
11/24/2005US20050261271 Dipeptidyl peptidase inhibitors
11/24/2005US20050261242 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents; oxidative and endothelial stress dysfunction; free radicals scavenger
11/24/2005US20050261198 sulfur-containing proanthocyanidin oligomer having a low molecular weight, made by reacting a precursor with a mercapto compound has improved bioavailability; antioxidant; derived from buckwheat
11/24/2005US20050260228 Vaccines absorbable by the transmucosal way
11/24/2005DE102004020081A1 Formulation having cyclooxygenase inhibiting activity, useful e.g. as antioxidants and to treat pain, liver cirrhosis and Parkinson's disease, comprises components or extracts of Byrsocarpus coccineus and Diodia scandens plants
11/24/2005CA2565084A1 Use of sulglicotide for the treatement of mucositis
11/23/2005EP1598071A1 Superoxide anion decomposing agent
11/23/2005EP1597284A2 Per (3,6-anhydro) cyclodextrine derivatives, production and use thereof in transporting metal elements to biological targets or in order to decontaminate biological fluids or targets
11/23/2005EP1597236A1 Growth promotion method
11/23/2005EP1597199A1 THERAPEUTIC MALONIC ACID/ACETIC ACID C sb 60 /sb TRI-ADDUCTS OF BUCKMINSTERFULLERENE AND METHODS RELATED THERETO
11/23/2005EP1217983B1 Skincare composition against free radicals
11/17/2005US20050256303 Having antibacterial activity, antioxidative effect, inflammation inhibitory effect, in vivo substance transporting action, and enzymatic activity, used as a drug administration carrier
11/17/2005US20050256299 Vaccines
11/17/2005US20050256122 Substituted pyridazinones
11/17/2005US20050256079 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained
11/17/2005US20050255093 treating nervous system disorders induced by stroke or injury, injured by trauma to reduce oxidative stress, administering a conjugate of antioxidant enzyme and a clostridial neurotoxin cell binding domain, and a clostridial neurotoxin translocation domain; tissue-targeted therapy
11/16/2005EP1595936A1 Antioxidative composition and composition for external use
11/16/2005EP1594492A2 Novel inhibitors of formation of advanced glycation endproducts (ages)
11/16/2005EP1324809B1 Process for selectively extracting bioactive components
11/16/2005EP1131090B1 Use of paraoxanase-1 (pon-1) to decrease atheroma formation and hypercholesterolemia
11/16/2005CN1697658A Fermentation product and process for producing the same
11/16/2005CN1227245C Food product and producing method
11/15/2005US6964960 Indoloquinazolinones
11/15/2005US6964956 Enzyme inhibitors of the I kappa B kinase, therapeutic treatment of autoimmune diseases, inflammatory diseases and cancer; chemical intermediates, sulfiding, sulfonation, desulfonation, cyclization
11/10/2005WO2005105126A1 Active oxygen eliminator and moisturizer containing wild watermelon extract
11/10/2005US20050250848 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
11/09/2005EP1593382A1 Use of probiotic lactic bacteria for balancing the skin's immune system
11/09/2005EP1592669A2 Novel substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
11/09/2005EP1592435A1 Ophthalmic formulation for the prevention and treatment of ocular conditions
11/09/2005CN1694719A Casein derived peptides and uses thereof in therapy
11/09/2005CN1226040C Anti-anoxia health food composition
11/08/2005US6962933 cerebral hemorrhage/infarction, head trauma, spinal cord injury, brain edema, multiple sclerosis, Alzheimer's/Parkinson's disease, amyotrophic lateral sclerosis, diabetes, osteoporosis, Creutzfeldt-Jakob disease or virus infections
11/08/2005CA2251690C New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
11/07/2005CA2506492A1 Irrigation solution for use in ultrasound energy assisted surgery
11/03/2005WO2005103012A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
11/03/2005WO2005103007A1 Crystalline 6-ethoxy-2,2,4-trimethyl-tetrahydroquinoline and a method for the production thereof
11/03/2005WO2005102321A1 Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis
11/03/2005US20050245736 Low molecular weight oversulfated polysaccharide
11/03/2005US20050245570 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
1 ... 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 ... 191